Huron Consulting Group Inc.

Huron Consulting Group Inc. (HURN) Market Cap

Huron Consulting Group Inc. has a market capitalization of $2.13B.

Financials based on reported quarter end 2025-12-31

Price: $128.28

0.16 (0.12%)

Market Cap: 2.13B

NASDAQ · time unavailable

CEO: C. Mark Hussey

Sector: Industrials

Industry: Consulting Services

IPO Date: 2004-10-13

Website: https://www.huronconsultinggroup.com

Huron Consulting Group Inc. (HURN) - Company Information

Market Cap: 2.13B · Sector: Industrials

Huron Consulting Group Inc., a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Business Advisory, and Education. The Healthcare segment provides advisory services in the areas of financial and operational improvement, care transformation, and revenue cycle managed services; organizational transformation; and digital, technology and analytic solutions to national and regional hospitals, integrated health systems, academic medical centers, community hospitals, medical groups, and health plans. The Business Advisory segment offers cloud-based technology, analytics, restructuring, and capital advisory solutions to life science, financial, healthcare, education, energy and utilities, and industrials and manufacturing industries, as well as to public sectors. The Education segment provides research enterprise and student lifecycle; digital, technology and analytic solutions; and organizational transformation services to public and private colleges and universities, academic medical centers, research institutes, and other not-for-profit organizations. Huron Consulting Group Inc. was incorporated in 2002 and is headquartered in Chicago, Illinois.

Analyst Sentiment

83%
Strong Buy

Based on 9 ratings

Analyst 1Y Forecast: $197.50

Average target (based on 2 sources)

Consensus Price Target

Low

$160

Median

$190

High

$240

Average

$197

Potential Upside: 53.3%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 HURON CONSULTING GROUP INC (HURN) — Investment Overview

🧩 Business Model Overview

Huron Consulting Group Inc. operates as a leading provider of management consulting services, serving organizations across healthcare, higher education, life sciences, and commercial sectors. The company specializes in delivering advisory, technology, and analytics solutions tailored to each client’s operational, strategic, and financial challenges. Huron positions itself as a value-added partner in organizational transformation, helping clients adapt to regulatory changes, drive operational efficiency, implement digital and cloud technologies, and enhance financial performance. Its engagement model often pairs deep subject-matter expertise with proprietary methodologies, enabling long-term client relationships and recurring business opportunities.

💰 Revenue Streams & Monetisation Model

Huron derives its revenues primarily through professional services billed on either a time-and-materials or fixed-fee basis. The company’s offerings are divided into three broad segments: Healthcare, Education, and Commercial. Consulting engagements, which include organizational strategy, digital transformation, and operational improvement, remain the core revenue generator. Additional revenue is earned from the implementation of enterprise solutions (such as ERP and cloud migration) and ongoing managed services. Huron also monetizes its proprietary analytics and data platforms, though these typically serve as enablers of broader consulting engagements rather than standalone products. Contract lengths can vary from short advisory projects to multi-year transformation initiatives, with repeat business and long-term partnerships forming a material component of Huron’s revenue mix.

🧠 Competitive Advantages & Market Positioning

Huron’s competitive positioning is defined by its domain expertise, especially in highly regulated and complex sectors such as healthcare and higher education. The firm benefits from deep, client-centric relationships and a reputation for driving measurable results. Its blend of advisory, technology, and analytics offerings allows Huron to provide end-to-end transformation solutions, differentiating it from boutique consultancies or large firms with less sector focus. A further advantage lies in its ability to cross-sell digital, analytics, and managed services across client engagements, driving stickiness and creating embedded client relationships. Huron’s ongoing investments in proprietary methodologies and emerging technologies enhance the value proposition and provide a barrier to commoditization versus industry peers.

🚀 Multi-Year Growth Drivers

Multiple secular trends underpin Huron’s long-term growth opportunity. In healthcare, pressures for cost containment, quality improvement, and ongoing regulatory change continue to fuel demand for consulting and digital transformation services. The higher education sector faces persistent challenges around financial sustainability, enrollment management, and digital disruption, all of which align with Huron’s core capabilities. On the commercial side, the increasing adoption of digital solutions, automation, and advanced analytics is driving demand across industries for Huron’s technology-centric offerings. The company’s strategic expansion into managed services and recurring-revenue models adds a layer of stability and longevity to its growth profile. Geographic expansion, as well as the diversification of offerings into life sciences and other regulated verticals, also support the company’s trajectory.

⚠ Risk Factors to Monitor

Investors should be attentive to several risk considerations. Huron operates in a highly competitive and fragmented consulting marketplace, with competition from both large global players and specialized boutiques. Shifts in regulatory environments, particularly within the healthcare and education sectors, can affect client spending patterns or the scope of permissible consulting engagements. The project-based nature of a significant portion of Huron’s revenue can introduce variability and cyclicality, especially during periods of economic uncertainty or reduced client budgets. Talent retention remains critical in consulting, as client relationships and intellectual capital are concentrated in personnel. Lastly, technological disruption—from evolving client demand to competitive technology-based offerings—poses a risk to traditional consulting models, underscoring the need for continuous innovation.

📊 Valuation & Market View

Huron’s valuation is typically benchmarked against both professional services and IT consulting firms, acknowledging its hybrid model. The market tends to recognize Huron’s sustained growth outlook, sector specialization, and recurring revenue expansion. Multiples are influenced by the company’s margin profile, earnings predictability, and scalability of its service offerings. Relative valuation may fluctuate based on industry capital flows, evolving perceptions around consulting demand in core sectors, and Huron’s success in driving higher-margin, technology-enabled services. The company’s ability to generate robust free cash flow and deploy capital into strategic acquisitions or share repurchases is often noted as a supporting factor for shareholder returns.

🔍 Investment Takeaway

Huron Consulting Group represents a compelling case for exposure to secular growth themes in healthcare, education, and technology-enabled business transformation. The company’s sector-focused expertise, enduring client relationships, and ongoing expansion into digital and managed services offer both resilience and upside in a dynamic end-market environment. While risks such as client budget cycles, talent dependence, and sector-specific regulations warrant monitoring, Huron’s strategic positioning and innovation-centric culture afford it multiple, diversified growth avenues. Overall, Huron stands as a differentiated professional services firm, well-placed to capture increasing demand for strategic transformation and operational improvement across critical industries.

⚠ AI-generated — informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"HURN reported revenue of $441.96M and a net income of $30.65M. The earnings per share (EPS) stands at $1.77. The company has substantial assets totaling $1.53B, with liabilities of $998.05M, leading to total equity of $528.63M and net debt of $523.83M. Operating cash flow is strong at $126.41M, with a free cash flow of $123.83M. Despite these strong fundamentals, HURN's market performance has faced significant challenges, with a 1-year price change of -12.61% and a year-to-date decline of -27.01%. This downward trend could signal investor concerns regarding future growth prospects amidst existing leverage."

Revenue Growth

Neutral

Solid revenue of $441.96M indicates a growth trajectory.

Profitability

Neutral

Net income of $30.65M suggests reasonable profitability.

Cash Flow Quality

Positive

Strong operating and free cash flow indicating good cash management.

Leverage & Balance Sheet

Fair

Moderate leverage with net debt at $523.83M, warrants attention.

Shareholder Returns

Neutral

Negative price change reflects inadequate shareholder returns despite no dividends.

Analyst Sentiment & Valuation

Caution

Price targets indicate limited upside from current levels, reflecting cautious sentiment.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Management delivered strong top-line and margin progress: Q4 RBR +11.3% YoY to $432.3M, full-year RBR +11.9% to $1.66B, and adjusted EBITDA margin expanded to 15.7% in Q4 (up ~110 bps). Adjusted EPS remains firmly on an upswing: full-year adjusted diluted EPS $7.83 (+21% YoY). The 2026 outlook calls for RBR of $1.78B–$1.86B and adjusted EBITDA margin of 14.5%–15.0%, with the midpoint implying ~+50 bps vs 2025 and EPS midpoint of $8.75 (+12%). However, the transcript also contains clear operational stress points: Education Q4 operating margin fell (20.7% vs 22.4%) due to higher salaries, third-party fees, restructuring, and next-gen research software amortization; Commercial full-year margin compressed (17.2% vs 20%) reflecting integration costs and cost increases. Importantly, no Q&A segment was included, so we cannot contrast management tone versus analyst pressure on specific hurdles.

AI IconGrowth Catalysts

  • Record RBR growth in Healthcare and Commercial in Q4 2025 (Q4 RBR +11.3% YoY; full-year RBR +11.9% YoY)
  • Healthcare momentum extended into 2026; bookings in 2H25 exceeded 2H24 by >20%
  • Commercial digital demand and “20%+” bookings growth in 2H25 vs 2H24
  • Digital capability RBR growth (+4% in Q4; +10% for full year 2025) and digital/data/AI business growing >40% in 2025 vs 2024
  • AI and automation deployments: “over 100” AI/automation solutions deployed to date (per CEO)

Business Development

  • Acquired AXIOM Systems’ consulting services division (payer-focused core administration systems + digital transformation; closed in 4Q per CEO)
  • Acquisitions contributing to Healthcare RBR: Eclipse Insights, AXIA, and AXIOM (Consulting Services division; closed Nov 1)
  • Acquisitions contributing to Commercial RBR: AXIA, Treliant, and Wilson Perumal (Wilson Perumal closed Sep 2025; included full quarter in Q4)
  • Technology partner collaboration with “select healthcare-focused AI companies” (named company: Hippocratic AI mentioned as a collaboration/partner ecosystem example)

AI IconFinancial Highlights

  • Q4 2025 RBR: $432.3M, +11.3% YoY vs $388.4M
  • Full-year 2025 RBR: $1.66B, +11.9% YoY vs $1.49B (organic RBR +7.1% excluding acquisitions and Studer divestiture)
  • Q4 2025 adjusted EBITDA: $68.0M, 15.7% of RBR vs $56.8M, 14.6% of RBR (bps expansion: +110 bps)
  • Full-year 2025 adjusted EBITDA: $237.5M, 14.3% of RBR vs $201.2M, 13.5% of RBR (bps expansion: +80 bps)
  • Adjusted net income: Q4 $38.7M ($2.17 EPS) vs Q4 2024 $35.2M ($1.90 EPS); full-year $140.8M ($7.83 EPS) vs $120.4M ($6.47 EPS) (+21% adjusted diluted EPS YoY
  • GAAP EPS: Q4 2025 diluted EPS $1.72 vs $1.84 in Q4 2024; GAAP net income Q4 $30.7M vs $34.0M (net income as % of revenue fell to 6.9% from 8.5%)
  • Tax: Q4 2025 effective tax rate 29.2% (less favorable; due to nondeductible items); full-year 2025 effective tax rate 22.2% (discrete share-based comp benefit, partially offset by nondeductibles)
  • Net income headwind/tailwind items: Q4 2025 includes $2.2M acquisition-related contingent consideration charges (net of tax); Q4 2024 included $2.4M gain from Studer divestiture (net of tax)
  • Full-year net income down: $105M ($5.84 EPS) vs $116.6M ($6.27 EPS), with 2025 including $7.7M noncash impairment charges tied to convertible debt investment

AI IconCapital Funding

  • No buyback/debt issuance amounts or cash runway discussed in the provided transcript excerpt beyond balance sheet levels
  • Cash (Dec 31, 2025): $24.5M
  • Total debt (Dec 31, 2025): $511M (senior bank debt only)
  • Net debt (Dec 31, 2025): $486.5M
  • Free cash flow (FY 2025): $162.3M (CFO $193.4M; capex $31.1M, inclusive of internally developed software costs)

AI IconStrategy & Ops

  • Margin expansion emphasized: adjusted EBITDA margin 15.7% in Q4 and 14.3% for full year; company cited +400 bps adjusted EBITDA margin expansion since 2020
  • Commercial integration costs and mix shift: full-year Commercial operating income margin decreased to 17.2% (vs 20% in 2024), attributed to salary/contractor cost increases and integration expenses during acquisition year
  • Healthcare operating margin improved: Q4 healthcare operating income margin 32.4% vs 30.3% (Q4 driven by lower performance bonus/salaries/support contractor costs partially offset by higher revenue-professional salaries as % of RBR)
  • Education operating margin compression in Q4: 20.7% vs 22.4% due to higher salaries/3rd-party fees/restructuring and capitalized software amortization related to next-gen research suite software
  • Working capital: DSO improved to 73 days in Q4 2025 from 76 days (Q3 2025 and Q4 2024) due to collection timing on larger Healthcare and Education projects

AI IconMarket Outlook

  • 2026 guidance (management): RBR $1.78B to $1.86B
  • 2026 guidance (midpoint): ~9.5% RBR growth
  • 2026 adjusted EBITDA margin: 14.5% to 15.0% of RBR
  • 2026 margin midpoint: ~+50 bps improvement vs 2025
  • 2026 adjusted diluted EPS: $8.35 to $9.15; midpoint $8.75 (+12% vs 2025 adjusted diluted EPS midpoint; company states 12% increase vs 2025)
  • 2029 target: 15% to 17% adjusted EBITDA margins
  • Backlog/pipeline: strongest hard backlog coverage of initial annual RBR guidance in last 5 years; pipeline near record levels even after strong sales conversions

AI IconRisks & Headwinds

  • No explicit analyst Q&A section provided in the transcript excerpt, so specific candid Q&A hurdles/pressures are not extractable here
  • Operational/market challenges described by management (not in Q&A): Healthcare providers face uneven financial performance due to reimbursement pressure, rising operating costs, and workforce constraints
  • Healthcare client posture: increased scenario planning and balance sheet resilience; payer mix and Medicaid/Medicare shifts or further cost increases could erode gains
  • Education clients: higher education operating environment pressure tied to regulatory environment, declining perception of 4-year degree value, and revenue/cost pressures (noted as higher risk conditions for universities)
  • Commercial environment: heightened complexity from regulatory change, cost pressure, and adoption of AI-enabled operating models (execution risk implied by need for integrated solutions)

Sentiment: MIXED

Note: This summary was synthesized by AI from the HURN Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (HURN)

© 2026 Stock Market Info — Huron Consulting Group Inc. (HURN) Financial Profile